Andrew Gengos
CFO
Terns Pharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Gengos
Andrew Gengos is recorded as CFO at Terns Pharmaceuticals, Inc. and CFO at Immuneering Corp (IMRX). Immuneering Corp reported in an 8-K filed June 15, 2026 that Andrew Gengos was appointed Chief Financial Officer and Treasurer. Terns Pharmaceuticals, Inc. reported in an 8-K filed February 24, 2025 that Andrew Gengos was appointed Chief Financial Officer, effective February 24, 2025.
“On June 11, 2026, the Board of Directors (the "Board") of Immuneering Corporation (the "Company") appointed Andrew Gengos as the Chief Financial Officer and Treasurer of the Company, to become effective on the commencement of his employment with the Company, which is expected to be on or before July 16, 2026 (the date Mr. Gengos actually commences employment with the Company, the "Effective Date").”
“On February 22, 2025, Terns Pharmaceuticals, Inc. ("Terns"), Terns, Inc. and Andrew Gengos entered into an employment agreement (the "Gengos Agreement") pursuant to which Mr. Gengos will serve as the Chief Financial Officer of Terns, effective as of February 24, 2025 (the "Start Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-15–present
-
Terns Pharmaceuticals, Inc.
CFO
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Terns Pharmaceuticals, Inc.
CFO
Leadership on record at Immuneering Corp
Other people whose current roles at this company are on record from its filings.
- Benjamin Zeskind CEO, Board Member
- Biren Amin CFO
- Michael D. Bookman General Counsel, Board Member
- Mallory Morales Chief Accounting Officer, Board Member
- Brett Hall Board Member
- Harold E. Brakewood Board Member
- Igor Matushansky Board Member
- Laurie B. Keating Board Member
- Leah R. Neufeld Board Member
- Peter Feinberg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.